INAB
IN8bio, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.20
+3.45%Jun 1, 2026, 00:00 UTC
IN8BIO, Inc. terminated its Controlled Equity Offering Sales Agreement with Cantor Fitzgerald, effective May 29, 2026.
Jun 1, 2026, 00:00 UTC
IN8BIO, Inc. entered into a Capital on Demand Sales Agreement with JonesTrading Institutional Services LLC to sell common stock from time to time in an at-the-market offering.